457 related articles for article (PubMed ID: 19652870)
1. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis.
Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E
Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870
[TBL] [Abstract][Full Text] [Related]
2. Reduction of atherosclerosis in mice by inhibition of CD40 signalling.
Mach F; Schönbeck U; Sukhova GK; Atkinson E; Libby P
Nature; 1998 Jul; 394(6689):200-3. PubMed ID: 9671306
[TBL] [Abstract][Full Text] [Related]
3. CD40 and its ligand in atherosclerosis.
Lutgens E; Lievens D; Beckers L; Donners M; Daemen M
Trends Cardiovasc Med; 2007 May; 17(4):118-23. PubMed ID: 17482093
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand is selectively expressed on CD4+ T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis.
Büchner K; Henn V; Gräfe M; de Boer OJ; Becker AE; Kroczek RA
J Pathol; 2003 Oct; 201(2):288-95. PubMed ID: 14517846
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1.
Zirlik A; Maier C; Gerdes N; MacFarlane L; Soosairajah J; Bavendiek U; Ahrens I; Ernst S; Bassler N; Missiou A; Patko Z; Aikawa M; Schönbeck U; Bode C; Libby P; Peter K
Circulation; 2007 Mar; 115(12):1571-80. PubMed ID: 17372166
[TBL] [Abstract][Full Text] [Related]
6. CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease.
Rizvi M; Pathak D; Freedman JE; Chakrabarti S
Trends Mol Med; 2008 Dec; 14(12):530-8. PubMed ID: 18977174
[TBL] [Abstract][Full Text] [Related]
7. The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis.
Engel D; Seijkens T; Poggi M; Sanati M; Thevissen L; Beckers L; Wijnands E; Lievens D; Lutgens E
Semin Immunol; 2009 Oct; 21(5):308-12. PubMed ID: 19616449
[TBL] [Abstract][Full Text] [Related]
8. The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
Antoniades C; Bakogiannis C; Tousoulis D; Antonopoulos AS; Stefanadis C
J Am Coll Cardiol; 2009 Aug; 54(8):669-77. PubMed ID: 19679244
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine modulates the CD40/CD40L system.
Prontera C; Martelli N; Evangelista V; D'Urbano E; Manarini S; Recchiuti A; Dragani A; Passeri C; Davì G; Romano M
J Am Coll Cardiol; 2007 Jun; 49(22):2182-90. PubMed ID: 17543638
[TBL] [Abstract][Full Text] [Related]
10. CD40/CD40L signaling and its implication in health and disease.
Chatzigeorgiou A; Lyberi M; Chatzilymperis G; Nezos A; Kamper E
Biofactors; 2009; 35(6):474-83. PubMed ID: 19904719
[TBL] [Abstract][Full Text] [Related]
11. CD40 and vascular inflammation.
Urbich C; Dimmeler S
Can J Cardiol; 2004 May; 20(7):681-3. PubMed ID: 15197419
[TBL] [Abstract][Full Text] [Related]
12. TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells.
Zirlik A; Bavendiek U; Libby P; MacFarlane L; Gerdes N; Jagielska J; Ernst S; Aikawa M; Nakano H; Tsitsikov E; Schönbeck U
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1101-7. PubMed ID: 17332487
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II modulates CD40 expression in vascular smooth muscle cells.
Souza HP; Frediani D; Cobra AL; Moretti AI; Jurado MC; Fernandes TR; Cardounel AJ; Zweier JL; Tostes RC
Clin Sci (Lond); 2009 Mar; 116(5):423-31. PubMed ID: 18785879
[TBL] [Abstract][Full Text] [Related]
14. Internalization of CD40 regulates its signal transduction in vascular endothelial cells.
Chen Y; Chen J; Xiong Y; Da Q; Xu Y; Jiang X; Tang H
Biochem Biophys Res Commun; 2006 Jun; 345(1):106-17. PubMed ID: 16677604
[TBL] [Abstract][Full Text] [Related]
15. CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system.
Chen K; Huang J; Gong W; Zhang L; Yu P; Wang JM
Cell Mol Immunol; 2006 Jun; 3(3):163-9. PubMed ID: 16893496
[TBL] [Abstract][Full Text] [Related]
16. ICOS is critical for CD40-mediated antibody class switching.
McAdam AJ; Greenwald RJ; Levin MA; Chernova T; Malenkovich N; Ling V; Freeman GJ; Sharpe AH
Nature; 2001 Jan; 409(6816):102-5. PubMed ID: 11343122
[TBL] [Abstract][Full Text] [Related]
17. The CD40-CD40L system in cardiovascular disease.
Pamukcu B; Lip GY; Snezhitskiy V; Shantsila E
Ann Med; 2011 Aug; 43(5):331-40. PubMed ID: 21244217
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil CD40 enhances platelet-mediated inflammation.
Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
[TBL] [Abstract][Full Text] [Related]
19. Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells.
Bavendiek U; Zirlik A; LaClair S; MacFarlane L; Libby P; Schönbeck U
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1244-9. PubMed ID: 15746436
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone inhibits CD40/CD40L expression on human umbilical vein endothelial cells induced by interferon gamma.
Li Y; Xia Z; Wang M
Int Immunopharmacol; 2009 Feb; 9(2):168-72. PubMed ID: 19015047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
